We are please to announce the first roadshow of a Nasdaq company Innovate Biopharmaceuticals in Paris with MyDCA on the 11 and 12 of April.

As the company is taking all the costs of it, Investors can join for free the event. So fell free to login on MyDCA, www.mydca.eu to create an account to join the roadshow.

Innovate Biopharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing autoimmune and inflammation therapeutics. Its late-stage clinical pipeline focuses on addressing unmet needs in diseases, such as celiac disease, inflammatory bowel disease (IBD), and nonalcoholic steatohepatitis (NASH).

If you have any question feel free to contact us.